IONS IONIS PHARMACEUTICALS INC
Nasdaq · SEC CIK 874015 · EDGAR
- Bought, last 12 months
- $1.06M 1 purchases by 1 insiders
- Sold, last 12 months
- $155.27M 88 sales by 19 insiders
- Filings on record
- 492 since 2021-07-06, latest 2026-09-02 20:32
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Monia Brett P | CEO, Dir | — | $30.35M |
| HOUGEN ELIZABETH L | EVP, CFO, Fin | — | $21.12M |
| BENNETT C FRANK | EVP, CSO | — | $16.71M |
| Geary Richard S | EVP, Chief Development Off | — | $13.35M |
| O'NEIL PATRICK R. | GC, EVP CLO | — | $9.17M |
| Devers Shannon L. | EVP, Chief Human Resources Ofc | — | $8.66M |
| Swayze Eric | EVP Research | — | $7.51M |
| LOSCALZO JOSEPH | Dir | — | $7.09M |
| KLEIN JOSEPH III | Dir | — | $6.00M |
| WENDER JOSEPH H | Dir | — | $5.44M |
Transactions 537
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-09-04 | 2025-09-03 | IONS | Monia Brett P | CEO, Dir | M - OptEx | $44.32 | +203.8K | 308.3K | +195% | +$9.03M |
| 2025-09-03 | 2025-08-29 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | J - Other | $27.71 | +331 | 57.1K | +0.6% | +$9,172 | |
| 2025-09-03 | 2025-08-29 | IONS | BENNETT C FRANK | EVP, CSO | J - Other | $27.71 | +213 | 93.7K | +0.2% | +$5,902 | |
| 2025-09-03 | 2025-08-29 | IONS | Birchler Brian | EVP, Corp, Development Ops | J - Other | $27.71 | +166 | 56.8K | +0.3% | +$4,600 | |
| 2025-09-03 | 2025-08-29 | IONS | Geary Richard S | EVP, Chief Development Off | J - Other | $27.71 | +165 | 89.7K | +0.2% | +$4,572 | |
| 2025-09-03 | 2025-08-29 | IONS | Monia Brett P | CEO, Dir | J - Other | $27.71 | +189 | 180.0K | +0.1% | +$5,237 | |
| 2025-08-26 | 2025-08-22 | IONS | Diaz Allene M. | Dir | S - Sale | $42.53 | -1,427 | 18.4K | -7% | -$60.7K | |
| D | 2025-08-20 | 2025-08-18 | IONS | BENNETT C FRANK | EVP, CSO | S - Sale+OE | $43.98 | -10.0K | 93.5K | -10% | -$439.8K |
| D | 2025-08-20 | 2025-08-18 | IONS | BENNETT C FRANK | EVP, CSO | M - OptEx | $32.60 | +10.0K | 103.5K | +11% | +$326.0K |
| M | 2025-08-08 | 2025-08-06 | IONS | PARSHALL B LYNNE | Dir | S - Sale | $41.93 | -5,000 | 86.7K | -5% | -$209.7K |
| 2025-08-06 | 2025-08-05 | IONS | Geary Richard S | EVP, Chief Development Off | S - Sale | $42.86 | -10.0K | 89.5K | -10% | -$428.6K | |
| 2025-08-05 | 2025-08-04 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale | $42.80 | -9,549 | 51.5K | -16% | -$408.7K | |
| D | 2025-08-01 | 2025-07-30 | IONS | Monia Brett P | CEO, Dir | S - Sale+OE | $45.00 | -2,432 | 179.8K | -1% | -$109.4K |
| D | 2025-08-01 | 2025-07-30 | IONS | Monia Brett P | CEO, Dir | M - OptEx | $32.60 | +2,432 | 182.3K | +1% | +$79.3K |
| D | 2025-07-17 | 2025-07-15 | IONS | BERTHELSEN SPENCER R | Dir | M - OptEx | $0.00 | +4,079 | 156.0K | +3% | $0 |
| D | 2025-07-17 | 2025-07-15 | IONS | Diaz Allene M. | Dir | M - OptEx | $0.00 | +4,079 | 19.8K | +26% | $0 |
| D | 2025-07-17 | 2025-07-15 | IONS | PARSHALL B LYNNE | Dir | M - OptEx | $0.00 | +4,079 | 91.3K | +5% | $0 |
| D | 2025-07-17 | 2025-07-15 | IONS | HERMAN JOAN E | Dir | M - OptEx | $0.00 | +4,079 | 46.1K | +10% | $0 |
| D | 2025-07-17 | 2025-07-15 | IONS | LOSCALZO JOSEPH | Dir | M - OptEx | $0.00 | +4,079 | 36.3K | +13% | $0 |
| D | 2025-07-17 | 2025-07-15 | IONS | YANG MICHAEL J. | Dir | M - OptEx | $0.00 | +4,079 | 6,010 | +211% | $0 |
| D | 2025-07-17 | 2025-07-15 | IONS | Hayden Michael R | Dir | M - OptEx | $0.00 | +4,079 | 54.3K | +8% | $0 |
| DI | 2025-07-17 | 2025-07-15 | IONS | WENDER JOSEPH H | Dir | M - OptEx | $0.00 | +4,079 | 136.8K | +3% | $0 |
| 2025-07-15 | 2025-07-11 | IONS | Monia Brett P | CEO, Dir | S - Sale | $41.74 | -1,160 | 179.8K | -0.6% | -$48.4K | |
| 2025-05-02 | 2025-05-01 | IONS | Hayden Michael R | Dir | P - Purchase | $31.86 | +15.0K | 50.2K | +43% | +$477.9K | |
| D | 2025-04-17 | 2025-04-15 | IONS | Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | M - OptEx | $0.00 | +12.2K | 14.2K | +615% | $0 |
| D | 2025-04-17 | 2025-04-16 | IONS | Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | S - Sale+OE | $28.36 | -3,016 | 11.2K | -21% | -$85.5K |
| D | 2025-04-17 | 2025-04-16 | IONS | Baroldi Joseph | EVP, Chief Business Off | S - Sale+OE | $28.40 | -3,928 | 31.9K | -11% | -$111.6K |
| D | 2025-04-17 | 2025-04-15 | IONS | Baroldi Joseph | EVP, Chief Business Off | M - OptEx | $0.00 | +10.8K | 35.9K | +43% | $0 |
| D | 2025-04-17 | 2025-04-15 | IONS | Birchler Brian | EVP, Corp, Development Ops | M - OptEx | $0.00 | +1,875 | 57.3K | +3% | $0 |
| D | 2025-04-17 | 2025-04-16 | IONS | Birchler Brian | EVP, Corp, Development Ops | S - Sale+OE | $28.37 | -680 | 56.7K | -1% | -$19.3K |
| 2025-03-13 | 2025-03-11 | IONS | Monia Brett P | CEO, Dir | S - Sale | $32.32 | -140 | 181.0K | -0.1% | -$4,525 | |
| 2025-03-04 | 2025-02-28 | IONS | BENNETT C FRANK | EVP, CSO | J - Other | $28.21 | +320 | 93.5K | +0.3% | +$9,027 | |
| 2025-03-04 | 2025-02-28 | IONS | Birchler Brian | EVP, Corp, Development Ops | J - Other | $28.21 | +414 | 55.5K | +0.8% | +$11.7K | |
| 2025-03-04 | 2025-02-28 | IONS | Swayze Eric | EVP Research | J - Other | $28.21 | +415 | 48.4K | +0.9% | +$11.7K | |
| 2025-03-04 | 2025-02-28 | IONS | Monia Brett P | CEO, Dir | J - Other | $28.21 | +437 | 181.1K | +0.2% | +$12.3K | |
| 2025-03-04 | 2025-02-28 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | J - Other | $28.21 | +554 | 56.8K | +1.0% | +$15.6K | |
| 2025-03-04 | 2025-02-28 | IONS | Geary Richard S | EVP, Chief Development Off | J - Other | $28.21 | +415 | 99.5K | +0.4% | +$11.7K | |
| 2025-02-24 | 2025-02-20 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | S - Sale | $32.35 | -1,207 | 56.2K | -2% | -$39.0K | |
| 2025-02-06 | 2025-02-04 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | S - Sale | $31.62 | -6,165 | 57.5K | -10% | -$194.9K | |
| 2025-02-06 | 2025-02-04 | IONS | Monia Brett P | CEO, Dir | S - Sale | $31.65 | -38.8K | 180.7K | -18% | -$1.23M | |
| 2025-02-03 | 2025-01-30 | IONS | HOUGEN ELIZABETH L | EVP, CFO, Fin | A - Grant | $0.00 | +4,138 | 112.0K | +4% | $0 | |
| 2025-02-03 | 2025-01-31 | IONS | HOUGEN ELIZABETH L | EVP, CFO, Fin | S - Sale | $32.44 | -1,523 | 110.5K | -1% | -$49.4K | |
| 2025-02-03 | 2025-01-31 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | S - Sale | $32.49 | -1,406 | 63.6K | -2% | -$45.7K | |
| 2025-02-03 | 2025-01-30 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | A - Grant | $0.00 | +3,820 | 65.0K | +6% | $0 | |
| 2025-02-03 | 2025-01-31 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale | $32.20 | -1,484 | 61.1K | -2% | -$47.8K | |
| 2025-02-03 | 2025-01-30 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | A - Grant | $0.00 | +4,032 | 62.5K | +7% | $0 | |
| 2025-02-03 | 2025-01-30 | IONS | BENNETT C FRANK | EVP, CSO | A - Grant | $0.00 | +3,607 | 94.5K | +4% | $0 | |
| 2025-02-03 | 2025-01-31 | IONS | BENNETT C FRANK | EVP, CSO | S - Sale | $32.46 | -1,327 | 93.1K | -1% | -$43.1K | |
| 2025-02-03 | 2025-01-31 | IONS | Monia Brett P | CEO, Dir | S - Sale | $32.45 | -13.2K | 219.5K | -6% | -$429.7K | |
| 2025-02-03 | 2025-01-30 | IONS | Monia Brett P | CEO, Dir | A - Grant | $0.00 | +25.4K | 232.8K | +12% | $0 | |
| 2025-02-03 | 2025-01-31 | IONS | Swayze Eric | EVP Research | S - Sale | $32.31 | -1,367 | 48.0K | -3% | -$44.2K | |
| 2025-02-03 | 2025-01-30 | IONS | Swayze Eric | EVP Research | A - Grant | $0.00 | +3,714 | 49.4K | +8% | $0 | |
| 2025-02-03 | 2025-01-31 | IONS | Geary Richard S | EVP, Chief Development Off | S - Sale | $32.40 | -1,406 | 99.1K | -1% | -$45.6K | |
| 2025-02-03 | 2025-01-30 | IONS | Geary Richard S | EVP, Chief Development Off | A - Grant | $0.00 | +3,820 | 100.5K | +4% | $0 | |
| D | 2025-01-17 | 2025-01-15 | IONS | Baroldi Joseph | EVP, Chief Business Off | M - OptEx | $0.00 | +8,787 | 28.4K | +45% | $0 |
| DI | 2025-01-17 | 2025-01-16 | IONS | Baroldi Joseph | EVP, Chief Business Off | S - Sale+OE | $32.70 | -1,029 | 3,071 | -25% | -$33.6K |
| DI | 2025-01-17 | 2025-01-15 | IONS | Baroldi Joseph | EVP, Chief Business Off | M - OptEx | $0.00 | +2,460 | 4,100 | +150% | $0 |
| D | 2025-01-17 | 2025-01-16 | IONS | Baroldi Joseph | EVP, Chief Business Off | S - Sale+OE | $32.70 | -3,401 | 25.0K | -12% | -$111.2K |
| D | 2025-01-17 | 2025-01-15 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M - OptEx | $0.00 | +17.4K | 65.0K | +36% | $0 |
| D | 2025-01-17 | 2025-01-16 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $32.79 | -6,523 | 58.5K | -10% | -$213.9K |
| D | 2025-01-17 | 2025-01-16 | IONS | Monia Brett P | CEO, Dir | S - Sale+OE | $32.63 | -33.4K | 207.4K | -14% | -$1.09M |
| D | 2025-01-17 | 2025-01-15 | IONS | Monia Brett P | CEO, Dir | M - OptEx | $0.00 | +73.4K | 240.8K | +44% | $0 |
| D | 2025-01-17 | 2025-01-15 | IONS | Birchler Brian | EVP, Corp, Development Ops | M - OptEx | $0.00 | +14.3K | 60.5K | +31% | $0 |
| D | 2025-01-17 | 2025-01-16 | IONS | Birchler Brian | EVP, Corp, Development Ops | S - Sale+OE | $32.70 | -5,400 | 55.1K | -9% | -$176.6K |
| D | 2025-01-17 | 2025-01-16 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | S - Sale+OE | $32.83 | -7,360 | 61.2K | -11% | -$241.6K |
| D | 2025-01-17 | 2025-01-15 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | M - OptEx | $0.00 | +19.7K | 68.6K | +40% | $0 |
| D | 2025-01-17 | 2025-01-15 | IONS | HOUGEN ELIZABETH L | EVP, CFO, Fin | M - OptEx | $0.00 | +23.9K | 116.8K | +26% | $0 |
| D | 2025-01-17 | 2025-01-16 | IONS | HOUGEN ELIZABETH L | EVP, CFO, Fin | S - Sale+OE | $32.81 | -8,870 | 107.9K | -8% | -$291.0K |
| D | 2025-01-17 | 2025-01-15 | IONS | YANG MICHAEL J. | Dir | M - OptEx | $0.00 | +1,931 | 1,931 | New | $0 |
| D | 2025-01-17 | 2025-01-15 | IONS | Devers Shannon L. | EVP, Chief Human Resources Ofc | M - OptEx | $0.00 | +12.3K | 20.2K | +155% | $0 |
| D | 2025-01-17 | 2025-01-16 | IONS | Devers Shannon L. | EVP, Chief Human Resources Ofc | S - Sale+OE | $32.78 | -4,267 | 15.9K | -21% | -$139.9K |
| D | 2025-01-17 | 2025-01-15 | IONS | Geary Richard S | EVP, Chief Development Off | M - OptEx | $0.00 | +18.9K | 103.7K | +22% | $0 |
| D | 2025-01-17 | 2025-01-16 | IONS | Geary Richard S | EVP, Chief Development Off | S - Sale+OE | $32.86 | -7,072 | 96.7K | -7% | -$232.4K |
| D | 2025-01-17 | 2025-01-15 | IONS | BENNETT C FRANK | EVP, CSO | M - OptEx | $0.00 | +18.0K | 97.6K | +23% | $0 |
| D | 2025-01-17 | 2025-01-16 | IONS | BENNETT C FRANK | EVP, CSO | S - Sale+OE | $32.90 | -6,752 | 90.9K | -7% | -$222.1K |
| DI | 2025-01-17 | 2025-01-16 | IONS | Swayze Eric | EVP Research | S - Sale+OE | $32.70 | -22 | 184 | -11% | -$719.40 |
| D | 2025-01-17 | 2025-01-15 | IONS | Swayze Eric | EVP Research | M - OptEx | $0.00 | +19.1K | 52.8K | +57% | $0 |
| D | 2025-01-17 | 2025-01-16 | IONS | Swayze Eric | EVP Research | S - Sale+OE | $32.84 | -7,154 | 45.7K | -14% | -$234.9K |
| DI | 2025-01-17 | 2025-01-15 | IONS | Swayze Eric | EVP Research | M - OptEx | $0.00 | +49 | 206 | +31% | $0 |
| M | 2024-12-26 | 2024-12-23 | IONS | Hayden Michael R | Dir | P - Purchase | $36.22 | +5,000 | 32.7K | +18% | +$181.1K |
| 2024-11-14 | 2024-11-12 | IONS | Monia Brett P | CEO, Dir | S - Sale | $38.05 | -6,630 | 167.4K | -4% | -$252.3K | |
| 2024-11-14 | 2024-11-12 | IONS | Swayze Eric | EVP Research | S - Sale | $37.92 | -1,194 | 33.7K | -3% | -$45.3K | |
| 2024-11-14 | 2024-11-12 | IONS | LOSCALZO JOSEPH | Dir | S - Sale | $37.86 | -13.5K | 32.3K | -30% | -$511.4K | |
| DI | 2024-10-17 | 2024-10-15 | IONS | Swayze Eric | EVP Research | M - OptEx | $0.00 | +125 | 210 | +147% | $0 |
| DI | 2024-10-17 | 2024-10-16 | IONS | Swayze Eric | EVP Research | S - Sale+OE | $38.31 | -53 | 157 | -25% | -$2,030 |
| A | 2024-09-04 | 2024-02-02 | IONS | Geary Richard S | EVP, Chief Development Off | S - Sale | $50.04 | -1,995 | 87.3K | -2% | -$99.8K |
| 2024-09-04 | 2024-08-30 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | J - Other | $38.64 | +246 | 48.9K | +0.5% | +$9,505 | |
| 2024-09-04 | 2024-08-30 | IONS | BENNETT C FRANK | EVP, CSO | J - Other | $38.64 | +177 | 79.6K | +0.2% | +$6,839 | |
| 2024-09-04 | 2024-08-30 | IONS | Birchler Brian | EVP, Corp, Development Ops | J - Other | $38.64 | +12 | 46.2K | +0.0% | +$463.68 | |
| A | 2024-09-04 | 2024-02-02 | IONS | Monia Brett P | CEO, Dir | S - Sale | $49.37 | -23.9K | 173.7K | -12% | -$1.18M |
| A | 2024-09-04 | 2024-02-02 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale | $49.59 | -2,106 | 47.7K | -4% | -$104.4K |
| A | 2024-09-04 | 2024-02-02 | IONS | Monia Brett P | CEO, Dir | S - Sale | $49.37 | -23.9K | 173.7K | -12% | -$1.18M |
| A | 2024-09-04 | 2024-02-02 | IONS | Swayze Eric | EVP Research | S - Sale | $49.56 | -1,940 | 34.3K | -5% | -$96.1K |
| A | 2024-09-04 | 2024-02-02 | IONS | Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str, Oper Ofc | S - Sale | $49.60 | -2,162 | 35.8K | -6% | -$107.2K |
| A | 2024-09-04 | 2024-02-02 | IONS | HOUGEN ELIZABETH L | EVP, CFO, Fin | S - Sale | $49.54 | -2,162 | 92.9K | -2% | -$107.1K |
| 2024-09-04 | 2024-08-30 | IONS | Swayze Eric | EVP Research | J - Other | $38.64 | +11 | 34.9K | +0.0% | +$425.04 | |
| A | 2024-09-04 | 2024-02-02 | IONS | BENNETT C FRANK | EVP, CSO | S - Sale | $49.52 | -1,885 | 79.0K | -2% | -$93.3K |
| 2024-09-04 | 2024-08-30 | IONS | Monia Brett P | CEO, Dir | J - Other | $38.64 | +140 | 174.0K | +0.1% | +$5,410 | |
| A | 2024-09-04 | 2024-02-02 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | S - Sale | $49.67 | -1,995 | 48.6K | -4% | -$99.1K |
| 2024-09-04 | 2024-08-30 | IONS | Geary Richard S | EVP, Chief Development Off | J - Other | $38.64 | +11 | 84.8K | +0.0% | +$425.04 |
Purchase Sale Sale after option exercise All abbreviations